Content Types

Explained 1

View All

Why We Invested in Fervo Energy

By Dr. Rachel Slaybaugh

Essays 3

View All

Why We Invested in Fervo Energy

By Dr. Rachel Slaybaugh

Reinventing Cement for a Zero-Carbon Future

By Zachary Bogue

2021 and Deep Tech: Reasons for Optimism

By Matthew Ocko, Zachary Bogue

DCVC Announcements 27

View All

DCVC Announcements

DCVC 2025 Q4 update

DCVC Announcements

DCVC 2025 Q3 update

DCVC Announcements

DCVC 2025 Q2 update

DCVC Announcements

DCVC 2025 Q1 update

Q&A 12

View All

Automated, localized, fast: why a top apparel leader is getting behind unspun’s fabric tech

Reality Defender democratizes deepfake detection with public API launch

Reality Defender answers FINRA call

Deep tech to defeat deepfakes: Reality Defender is on the case

Snapshot 3

View All

Kanvas Bio speeds the search for microbiome therapies through industrial-scale imaging of gut and host cells

By Jason Pontin

CH4 Global set to launch world's first commercial scale Asparagopsis production facility

How Noetik uses images to give its AI model a deeper understanding of cancer

Company Profile 8

View All

Company Profile

Why Kanvas built its own production line for microbiome therapeutics

By Jason Pontin

Company Profile

Flexible Power for an inflexible grid: Why DCVC backed Mainspring Energy

Company Profile

Built to break barriers: How Grove Biopharma is architecting its way around traditional drug limits

By Dr. Emily Park, Dr. Kiersten Stead

Company Profile

Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners

By Dr. Justin Kern

News 126

View All

Fervo IPO

By Dr. Rachel Slaybaugh, Zachary Bogue

How the quantum race will be won on the factory floor

By Dr. Prineha Narang

Kanvas makes the microbiome druggable—and the implications are massive

By Jason Pontin

Neutralizing the swarm: Fortem cements its position as the go-to for drone defense

By Matthew Ocko

Thoughts 31

View All

Quantum’s super position

By Matthew Ocko, James Hardiman, Dr. Prineha Narang

Human identity needs a Zero Trust moment

Professor Prineha Narang joins DCVC as we double down on our historical quantum tech leadership

By Matthew Ocko, Zachary Bogue

The hard problem of hardware attacks

By James Hardiman

Deep Tech Opportunities Report 42

View All

Deep Tech Opportunities Report

Deep Tech Opportunity: Startup-built technologies are bringing us new ways to dominate in the air and in space

Deep Tech Opportunities Report

Deep Tech Opportunity: There’s an exciting new way to put protein-like drugs inside cells

Deep Tech Opportunities Report

Deep Tech Opportunity: It’s time to develop better drugs to treat anxiety

Deep Tech Opportunities Report

Deep Tech Opportunity: It’s time to overhaul regulation and reimbursement for one-and-done treatments